Account

Sign in to access your account and subscription

Litigation

  • Several items of interest.

    February 29, 2012ALM Staff | Law Journal Newsletters |
  • Last month, the authors began a discussion of the crucial role non-party physicians often play in medical malpractice cases. Here, they look at some methods for obtaining the evidence they possess.

    February 29, 2012John L.A. Lyddane and Barbara D. Goldberg
  • Obstetricians should examine their states' legal requirements about informed consent when making decisions about when to speak to patients about planned cesarean delivery in the face of evidence suggesting an increased risk of shoulder dystocia during delivery.

    February 29, 2012John Ratkowitz
  • This article concludes last month's overview and discussion of the impact on trusts arising from a recent New Jersey case, Tannen v. Tannen.

    February 29, 2012Martin M. Shenkman, Ira S. Herman, Judson M. Stein, Martin D. Hauptman and Carl J. Soranno
  • Independent Creation Testimony Defeats Rap Riff Copyright Claim
    Right to Percentage 'Equal to' Label's Net Receipts Doesn't Support Conversion Claim in Creedence Clearwater Digital Royalties Suit
    'Substantial Value' Allegation in Implied Contract Case Not Enough to Meet $75,000 Amount in Controversy for Federal Subject Matter Jurisdiction

    February 28, 2012Stan Soocher
  • This article concentrates on the scope of CDA immunity advertisers and entertainment companies that operate UGC campaigns may enjoy, limitations of the CDA in protecting against these claims and ways to structure UGC campaigns to minimize the risk of liability arising from unauthorized use of individuals' name, likeness and other personal attributes possibly included in UGC submitted as part of a sponsored UGC campaign.

    February 28, 2012Alan L. Friel and Jesse M. Brody
  • Habitually filing Daubert motions for every opposing expert is not smart trial practice. Here's why.

    February 28, 2012Thomas P. Branigan and Tina Georgieva
  • The Pennsylvania Superior Court has restored the $28 million in punitive damages a Philadelphia jury awarded to an Illinois plaintiff who said drugmakers Wyeth and Pharmacia & Upjohn Inc. failed to warn her doctor of the risks of breast cancer from using hormonal drugs. The trial judge had reduced the punitive damages award to $1 million.

    February 28, 2012Amaris Elliott-Engel